Merck’s new spin-off to focus on infertility treatment
Merck Serono announced the creation of TocopheRx, a Boston-based spin-off company resulting from its Entrepreneur Partnership Program (EPP) launched in April 2012. TocopheRx, the 8th spin-off in the EPP will focus on the development of oral follicle-stimulating hormone (FSH) agonists for treatment of infertility, by advancing Merck Serono's preclinical program towards clinical testing. Merck Serono will initially invest $ 3.2 million (approx. € 2.4 million) in seed funding.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Rapid imaging of granular matter
Millipore Corporation's re-branding underscores expanded capabilities and partnership with customers - Millipore Foundation awards $500,000 research gift to the Harvard Stem Cell Institute
Molecular motion in tire rubber - Tyre components observed with incredible time resolution
University of Leicester researchers discover new fluorescent silicon nanoparticles - Research may ultimately track the uptake of drugs by the body's cells
Bio-Techne to acquire Quad Technologies
BÜCHI acquires NIR-Online
Opto-electronic nose sniffs out toxic gases
ORNL scientists help explain graphene mystery
Altmann Analytik acquires lab supplier Dinkelberg analytics
New organ-on-chip pilot seeks to reduce animal testing in consumer health industry - Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital